LY3154885

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3154885, covering 2024-03-12 to 2024-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3154885 in Healthy Participants [Phase 1]